Drug-induced conformational changes in multidrug efflux transporter AcrB from Haemophilus influenzae
Vishakha Dastidar1, Weimin Mao, Olga Lomovskaya
1Department of Chemistry and Biochemistry, 620 Parrington Oval, Norman, OK 73019, USA.
Abstract:
In gram-negative bacteria, transporters belonging to the resistance-nodulation-cell division (RND) superfamily of proteins are responsible for intrinsic multidrug resistance. Haemophilus influenzae, a gram-negative pathogen causing respiratory diseases in humans and animals, constitutively produces the multidrug efflux transporter AcrB (AcrB(HI)). Similar to other RND transporters AcrB(HI) associates with AcrA(HI), the periplasmic membrane fusion protein, and the outer membrane channel TolC(HI). Here, we report that AcrAB(HI) confers multidrug resistance when expressed in Escherichia coli and requires for its activity the E. coli TolC (TolC(EC)) protein. To investigate the intracellular dynamics of AcrAB(HI), single cysteine mutations were constructed in AcrB(HI) in positions previously identified as important for substrate recognition. The accessibility of these strategically positioned cysteines to the hydrophilic thiol-reactive fluorophore fluorescein-5-maleimide (FM) was studied in vivo in the presence of various substrates of AcrAB(HI) and in the presence or absence of AcrA(HI) and TolC(EC). We report that the reactivity of specific cysteines with FM is affected by the presence of some but not all substrates. Our results suggest that substrates induce conformational changes in AcrB(HI).
Insights
Multidrug efflux pumps in gram-negative bacteria, like AcrB(HI) from Haemophilus influenzae, confer resistance. Substrate binding induces conformational changes in these transporters, impacting their function.
Area of Science:
- Microbiology
- Molecular Biology
- Biochemistry
Background:
- Gram-negative bacteria utilize Resistance-Nodulation-Cell Division (RND) superfamily transporters for intrinsic multidrug resistance.
- Haemophilus influenzae produces the AcrB(HI) multidrug efflux transporter, which functions with AcrA(HI) and TolC(HI).
Purpose of the Study:
- To investigate the in vivo dynamics and substrate-induced conformational changes of the AcrAB(HI) multidrug efflux transporter.
- To determine if AcrAB(HI) expressed in Escherichia coli requires E. coli's TolC (TolC(EC)) for activity.
Main Methods:
- Constructed single cysteine mutations in AcrB(HI) at substrate recognition sites.
- Assessed in vivo accessibility of these cysteines to fluorescein-5-maleimide (FM) in the presence/absence of substrates, AcrA(HI), and TolC(EC).
Main Results:
- AcrAB(HI) expressed in E. coli conferred multidrug resistance, dependent on TolC(EC).
- The reactivity of specific cysteines with FM was altered by certain substrates, indicating substrate-specific conformational changes in AcrB(HI).
Conclusions:
- Substrates induce conformational changes within the AcrB(HI) multidrug efflux transporter.
- Understanding these dynamics is crucial for developing strategies to combat bacterial multidrug resistance.
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
ABC Transporters: Exporter
Development of Antibiotic Resistance
GPCRs Regulate Adenylyl Cylase Activity
Two...
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
ABC Transporters: Importer
In bacteria, based on the number of transmembrane helices and the chemical nature of their substrates, the ABC importers can be divided into three types:


